- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Fisher Scientific acquires PSS World Medical
Fisher Scientific has acquired specialty medical marketer and distributor PSS World Medical in a tax-free, stock-for-stock transaction valued at $840 million. Fisher supplies laboratory supplies and equipment, e-commerce technology, and other services to
Fisher Scientific has acquired specialty medical marketer and distributor PSS World Medical in a tax-free, stock-for-stock transaction valued at $840 million. Fisher supplies laboratory supplies and equipment, e-commerce technology, and other services to the scientific research community.
In February, PSS hired an investment banking firm to help its board of directors investigate ways to increase the value of its stock for shareholders. PSS has been looking for an acquisition partner since then, the company said. The company had built a presence in the medical imaging industry through acquisitions and distribution agreements.
In 1996, PSS acquired Diagnostic Imaging. Three years later, Diagnostic Imaging signed an agreement with Philips Medical Systems North America that gave DI exclusive distribution rights to Philips Tomoscan EG CT and BV25 Gold Mobile C-arm systems. Last month Diagnostic Imaging revised a distribution agreement with SonoSite, allowing other companiessuch as ATL Ultrasoundto include the SonoSite 180 handheld ultrasound system with sales of their own ultrasound systems (SCAN 6/7/00).
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
